• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Incidence of Childhood Thyrotoxicosis Is Increasing in Both Girls and Boys in Sweden.瑞典男女童的甲状腺功能亢进症发病率均在上升。
Horm Res Paediatr. 2019;91(3):195-202. doi: 10.1159/000500265. Epub 2019 May 16.
2
Increasing Incidence of Juvenile Thyrotoxicosis in Denmark: A Nationwide Study, 1998-2012.丹麦青少年甲状腺毒症发病率上升:一项1998 - 2012年的全国性研究
Horm Res Paediatr. 2015;84(2):102-7. doi: 10.1159/000430985. Epub 2015 Jun 24.
3
Increasing incidence of childhood thyrotoxicosis in a population-based area of central Sweden.瑞典中部一个基于人群的地区儿童甲状腺毒症发病率不断上升。
Acta Paediatr. 2004 Jan;93(1):25-9. doi: 10.1080/08035250310008069.
4
Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.综合医疗服务体系中的妊娠甲状腺毒症、抗甲状腺药物使用与新生儿结局
Thyroid. 2015 Jun;25(6):698-705. doi: 10.1089/thy.2014.0434. Epub 2015 Apr 14.
5
Outcome of Graves' thyrotoxicosis after antithyroid drug treatment.
Changgeng Yi Xue Za Zhi. 1995 Dec;18(4):305-14.
6
Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study.
Eur J Endocrinol. 1994 Jun;130(6):565-8. doi: 10.1530/eje.0.1300565.
7
Management of Thyrotoxicosis in Children and Adolescents: A Turkish Multi-center Experience.儿童和青少年甲状腺毒症的管理:土耳其多中心经验
J Clin Res Pediatr Endocrinol. 2019 May 28;11(2):164-172. doi: 10.4274/jcrpe.galenos.2018.2018.0210. Epub 2018 Nov 29.
8
Thyrotoxicosis in children: treatment and outcome.儿童甲状腺毒症:治疗与转归
J Med Assoc Thai. 2006 Jul;89(7):967-73.
9
Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.格雷夫斯病和无痛性甲状腺炎所致甲状腺毒症患者肝功能检查的系列变化
Thyroid. 2008 Mar;18(3):283-7. doi: 10.1089/thy.2007.0189.
10
Evaluation and Management of Children with Thyrotoxicosis.甲状腺毒症患儿的评估与管理
Recent Pat Endocr Metab Immune Drug Discov. 2017;11(1):22-31. doi: 10.2174/1872214812666180327112540.

引用本文的文献

1
Overall, sex-and race/ethnicity-specific prevalence of thyroid dysfunction in US adolescents aged 12-18 years.美国 12-18 岁青少年甲状腺功能障碍的性别和种族/民族特异性流行率。
Front Public Health. 2024 Jun 20;12:1366485. doi: 10.3389/fpubh.2024.1366485. eCollection 2024.
2
Different doses of methimazole treatment of children and adolescents with graves' disease: a clinical study based on 161 cases of outpatients.不同剂量甲巯咪唑治疗儿童及青少年 Graves 病:基于 161 例门诊患者的临床研究。
BMC Endocr Disord. 2023 Oct 23;23(1):233. doi: 10.1186/s12902-023-01484-2.
3
Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease.用于评估和个性化儿科罕见病药物治疗的临床实用药代动力学计算机模型:在格雷夫斯病中的应用
Front Med (Lausanne). 2023 May 3;10:1099470. doi: 10.3389/fmed.2023.1099470. eCollection 2023.
4
Hyperthyroidism in children and adolescents: Experience in a university hospital in Colombia.儿童和青少年甲状腺功能亢进症:哥伦比亚一所大学医院的经验。
Biomedica. 2022 Jun 1;42(2):342-354. doi: 10.7705/biomedica.6244.
5
Graves' disease: moving forwards.格雷夫斯病:不断前行。
Arch Dis Child. 2023 Apr;108(4):276-281. doi: 10.1136/archdischild-2022-323905. Epub 2022 Jul 13.
6
[Definitive treatment of Graves' disease in children].[儿童格雷夫斯病的确定性治疗]
Probl Endokrinol (Mosk). 2022 Apr 11;68(2):104-111. doi: 10.14341/probl13086.
7
2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.2022年欧洲甲状腺协会儿童格雷夫斯病管理指南
Eur Thyroid J. 2022 Jan 1;11(1):e210073. doi: 10.1530/ETJ-21-0073.
8
Hyperthyroidism in adolescents.青少年甲状腺功能亢进症
Endocr Connect. 2021 Oct 25;10(11):R279-R292. doi: 10.1530/EC-21-0191.
9
How to use thionamide anti-thyroid drug in the young- what's new?如何在年轻人中使用硫酰胺类抗甲状腺药物——有哪些新进展?
Thyroid Res. 2021 Jul 21;14(1):18. doi: 10.1186/s13044-021-00109-x.
10
An Estimation of the Incidence of Thyroiditis Among Girls in Primary Care in Spain.在西班牙初级保健中估算少女甲状腺炎的发病率。
J Clin Res Pediatr Endocrinol. 2021 Jun 2;13(2):170-179. doi: 10.4274/jcrpe.galenos.2020.2020.0225. Epub 2020 Dec 2.

本文引用的文献

1
Controversies in the pharmacological treatment of Graves' disease in children.儿童 Graves 病药物治疗的争议。
Expert Rev Clin Pharmacol. 2018 Nov;11(11):1113-1121. doi: 10.1080/17512433.2018.1546576. Epub 2018 Nov 15.
2
Incidence and trend of type 1 diabetes and the underlying environmental determinants.1 型糖尿病的发病率和趋势及其潜在的环境决定因素。
Diabetes Metab Res Rev. 2019 Jan;35(1):e3075. doi: 10.1002/dmrr.3075. Epub 2018 Oct 11.
3
Graves' disease in children.儿童格雷夫斯病。
Ann Endocrinol (Paris). 2018 Dec;79(6):647-655. doi: 10.1016/j.ando.2018.08.001. Epub 2018 Aug 16.
4
Diagnosis and management of hyperthyroidism from prenatal life to adolescence.从胎儿期到青春期的甲状腺功能亢进症的诊断和治疗。
Best Pract Res Clin Endocrinol Metab. 2018 Aug;32(4):373-386. doi: 10.1016/j.beem.2018.03.014. Epub 2018 Apr 5.
5
Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies.手术治疗的格雷夫斯病甲亢患者中的偶发性甲状腺癌:一项队列研究的系统评价和荟萃分析
Cancer Manag Res. 2018 May 21;10:1201-1207. doi: 10.2147/CMAR.S164210. eCollection 2018.
6
Epidemiology of Childhood Hyperthyroidism in France: A Nationwide Population-Based Study.法国儿童甲亢的流行病学:一项全国性基于人群的研究。
J Clin Endocrinol Metab. 2018 Aug 1;103(8):2980-2987. doi: 10.1210/jc.2018-00273.
7
Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.苏格兰西部儿童和青少年甲状腺功能亢进症的长期预后:长期抗甲状腺治疗的必要性及初始咨询的重要性。
Arch Dis Child. 2018 Jul;103(7):637-642. doi: 10.1136/archdischild-2017-313454. Epub 2017 Dec 21.
8
Myasthenia gravis: a clinical-immunological update.重症肌无力:临床免疫学最新进展
J Neurol. 2016 Apr;263(4):826-34. doi: 10.1007/s00415-015-7963-5. Epub 2015 Dec 24.
9
Thyroid carcinoma in Graves' disease: A meta-analysis.格雷夫斯病中的甲状腺癌:一项荟萃分析。
Int J Surg. 2016 Mar;27:118-125. doi: 10.1016/j.ijsu.2015.11.027. Epub 2015 Nov 26.
10
McCune-Albright Syndrome: An Overview of Clinical Features.
J Pediatr Nurs. 2015 Sep-Oct;30(5):815-7. doi: 10.1016/j.pedn.2015.06.009. Epub 2015 Jul 21.

瑞典男女童的甲状腺功能亢进症发病率均在上升。

The Incidence of Childhood Thyrotoxicosis Is Increasing in Both Girls and Boys in Sweden.

机构信息

Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden,

出版信息

Horm Res Paediatr. 2019;91(3):195-202. doi: 10.1159/000500265. Epub 2019 May 16.

DOI:10.1159/000500265
PMID:31096231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690413/
Abstract

BACKGROUND

We found an increase in the incidence rate (IR) of childhood thyrotoxicosis (CT) during the 1990s in central Sweden. The optimal treatment method for CT is a subject that is still debated upon.

OBJECTIVES

To investigate whether the increase in IR of CT in Sweden persists and to study the treatment outcome.

METHOD

Children <16 years of age diagnosed with CT during 2000-2009 and living in 1 of 5 counties in central Sweden were identified retrospectively using hospital registers. Data on clinical and biochemical characteristics and outcomes of treatment were collected from medical records. The corresponding data from 1990 to 1999 were pooled with the new data.

RESULTS

In total, 113 children were diagnosed with CT during 1990-2009 in the study area. The overall IR was 2.2/100,000 person-years (95% CI 1.2-2.5/100,000 person-years). The IR was significantly higher during 2000-2009 than during 1990-1999 (2.8/100,000 [2.2-3.6] vs. 1.6/100,000 person-years [1.2-2.2], p = 0.006). The increase was significant for both sexes. Seventy percent of the patients who completed the planned initial treatment with antithyroid drugs (ATDs) and were not lost to follow-up relapsed within 3 years. Boys tended to relapse earlier than girls (6.0 months after drug withdrawal [95% CI 1.9-10.0] vs. 12.0 months [95% CI 6.8-17.3], p = 0.074).

CONCLUSIONS

The IR of CT is increasing in both girls and boys. Relapse rate after withdrawal of ATD treatment is 70%. Boys tend to relapse earlier than girls, and this needs to be further investigated.

摘要

背景

我们发现,在 20 世纪 90 年代,瑞典中部儿童甲状腺功能亢进症(CT)的发病率(IR)有所增加。CT 的最佳治疗方法仍是一个有争议的话题。

目的

调查瑞典 CT 的 IR 增加是否持续,并研究治疗结果。

方法

通过医院登记册,回顾性地确定了 2000-2009 年期间在瑞典中部 5 个县中诊断为 CT 的<16 岁儿童。从病历中收集了有关临床和生化特征以及治疗结果的数据。将 1990 年至 1999 年的数据与新数据合并。

结果

在研究区域,共有 113 名儿童在 1990-2009 年期间被诊断为 CT。总发病率为 2.2/100,000人年(95%CI 1.2-2.5/100,000 人年)。2000-2009 年的发病率明显高于 1990-1999 年(2.8/100,000[2.2-3.6]比 1.6/100,000 人年[1.2-2.2],p=0.006)。男女发病率均有显著增加。完成抗甲状腺药物(ATD)计划初始治疗且未失访的患者中,有 70%在 3 年内复发。男孩停药后复发的时间早于女孩(停药后 6.0 个月[95%CI 1.9-10.0]比 12.0 个月[95%CI 6.8-17.3],p=0.074)。

结论

女孩和男孩的 CT 发病率都在增加。ATD 治疗停药后的复发率为 70%。男孩停药后复发的时间早于女孩,这需要进一步研究。